Skip to main content

Month: April 2021

European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma

        European Commission approves second indication of Sarclisa®(isatuximab) for relapsed multiple myelomaApproval based on Phase 3 IKEMA study demonstrating Sarclisa added to standard of care carfilzomib and dexamethasone reduced risk of disease progression or death by 47% in patients who had relapsed after one to three prior therapies Sarclisa combination therapy was associated with undetectable levels of multiple myeloma (MM) in nearly 30% of patients with relapsed MM Second EU approval in less than 12 months for Sarclisa in combination with a standard of care regimen for the treatment of relapsed or refractory MMPARIS – April 19, 2021 – Today, the European Commission (EC) approved Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with relapsed multiple myeloma...

Continue reading

La Commission européenne approuve une seconde indication de Sarclisa® (isatuximab) pour le traitement du myélome multiple en rechute

        La Commission européenne approuve une seconde indication de Sarclisa®(isatuximab) pour le traitement du myélome multiple en rechuteApprobation fondée sur les résultats de l’étude IKEMA de phase III ayant démontré que l’ajout de Sarclisa à un traitement standard par carfilzomib et dexaméthasone réduit de 47 % le risque de progression de la maladie ou de décès chez les patients en rechute après un à trois traitements antérieurs. Le traitement associant Sarclisa s’est soldé par des taux indétectables de cellules du myélome multiple chez près de 30 % des patients en rechute. Deuxième approbation dans l’UE en moins de 12 mois pour Sarclisa en association avec un traitement standard pour le MM en rechute ou réfractaire.PARIS – Le 19 avril 2021 – La Commission européenne (CE) a approuvé aujourd’hui Sarclisa® (isatuximab) en association...

Continue reading

Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States

REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States Mont-Saint-Guibert, Belgium – 19 April 2021 – Nyxoah SA (Euronext Brussels: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has confidentially submitted a draft Registration Statement on Form F-1 to the Securities and Exchange Commission (the “SEC”) relating to the proposed public offering of its ordinary shares in the United States. The number of ordinary shares to be offered and the price for the proposed offering have not yet been determined. The public offering is expected to take place after the SEC completes its review process,...

Continue reading

Nyxoah annonce la soumission d’un projet de déclaration d’enregistrement pour une inscription publique proposée

INFORMATIONS RÉGLEMENTÉESINFORMATIONS PRIVILÉGIÉES Nyxoah annonce la soumission d’un projet de déclaration d’enregistrement pour une inscription publique proposée aux États-Unis Mont-Saint-Guibert, Belgique – le 19 avril 2021 – Nyxoah SA (Euronext Bruxelles : NYXH) (« Nyxoah » ou la « Société »), une société de technologies médicales spécialisée dans le développement et la commercialisation de solutions pour le traitement du Syndrome d’Apnées Obstructives du Sommeil (AOS), a annoncé aujourd’hui qu’elle avait soumis de manière confidentielle un projet de déclaration d’enregistrement sur le formulaire F-1 à la Securities and Exchange Commission (la « SEC ») concernant l’offre publique initiale proposée de ses actions ordinaires. Le nombre d’actions ordinaires à offrir et la fourchette...

Continue reading

Millicom signs agreements to conclude Africa divestiture program

Millicom signs agreements to conclude Africa divestiture program Luxembourg, April 19, 2021 – Millicom International Cellular S.A. (“Millicom”) announces that it has signed agreements for the sale of its operations in Tanzania and for its stake in the AirtelTigo joint venture in Ghana. Once closed, the transactions will complete Millicom’s multi-year plan to divest its African operations and focus on its Latin America markets. In Tanzania, Millicom has agreed to sell its entire operations to a consortium led by Axian, a pan-African group that was part of the consortium that acquired Millicom’s operations in Senegal in 2018. In Ghana, Millicom along with its joint venture partner, Bharti Airtel Limited, have signed a definitive agreement for the transfer of AirtelTigo to the Government of Ghana. Millicom will take a $25 million charge...

Continue reading

Hywin Holdings Announces Two Wins at WealthBriefingAsia Greater China Awards 2021

Hywin Wealth CEO Madame Wang Dian rings a gong at a ceremony in Shanghai to celebrate the company’s NASDAQ listing, March 26, 2021 SHANGHAI, China, April 19, 2021 (GLOBE NEWSWIRE) — Hywin Holdings Ltd. (“Hywin Wealth” or the “Company”, NASDAQ: HYW), a leading independent wealth manager in China, today announced that it was voted “Best Wealth Manager of Greater China 2021” at the WealthBriefingAsia Greater China Awards 2021. In addition, Hywin Wealth’s CEO Madame Wang Dian won the award of “Best CEO in Greater China Wealth Management 2021.” This year’s awards reflect the Company’s continued growth and outsized impact on the wealth management industry in Greater China, as well as Madame Wang’s leadership achievements. The recipient of the “Best Wealth Manager of Greater China” is selected by a panel of judges to recognize a company...

Continue reading

Nokia to deploy indoor 5G small cells solutions with LG Uplus in South Korea

Press Release Nokia to deploy indoor 5G small cells solutions with LG Uplus in South KoreaNokia will expand and enhance LG Uplus’ 5G network, enabling seamless 5G connectivity between indoor and outdoor locations LG Uplus will use Nokia’s AirScale indoor solution which can be deployed flexibly and upgraded easily The deal continues the long-standing partnership between the two companies19 April 2021 Espoo, Finland – Nokia today announced an agreement with LG Uplus to expand 5G coverage by installing new equipment from Nokia’s comprehensive AirScale portfolio across the country, enabling seamless 5G indoor and outdoor connectivity. The deal is expected to accommodate future network expansion and will further deepen the partnership between the two companies, which have already collaborated on LTE, 5G and digital projects. Being the...

Continue reading

Yellow Corporation Bringing New Jobs to Irving, Texas & America

OVERLAND PARK, Kan., April 18, 2021 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) is recruiting employees for new positions in Irving, Texas. On Tuesday, April 21 and Wednesday, April 22, Yellow will host a hiring event as the trucking company looks to fill jobs including: mechanics, local drivers, dock workers and linehaul drivers. Yellow intends to hire qualified individuals for more than 120 positions in Irving immediately with more positions opening nationwide. Yellow is the second largest less-than-truckload carrier and the fifth largest transportation company in North America. Yellow’s 30,000 employees are based in all 50 states as well as Puerto Rico, Canada and Mexico. Yellow’s Irving hiring day is one of more than two dozen similar recruiting events taking place across America between now and July. By the end of...

Continue reading

Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021

Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more favorable than expected progression of +9.2 points Improvement in neuropathy for 3 of these 7 evaluable patients demonstrated by a mean change in NIS of -3.33 points Improvement in cardiac function for all 7 evaluable patients demonstrated by a decrease in global longitudinal strain (GLS) Emerging Science Oral Presentation today at AAN 2021DUBLIN, Ireland, April 18, 2021 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA) today presented positive results from the Phase 1 study of PRX004 as part of the Emerging Science Session at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting. PRX004 showed favorable results as demonstrated by slowing of neuropathy progression for all 7 evaluable patients...

Continue reading

Kibali Goldmines Rejects SOKIMO Claim

KINSHASA, Democratic Republic of the Congo, April 18, 2021 (GLOBE NEWSWIRE) — Kibali Goldmines SA (Kibali) said today it had learned that SOKIMO SA was attempting for the second time to extort certain benefits from the company by filing new proceedings with the commercial court in Kinshasa. SOKIMO is a 10% shareholder in the Kibali gold mine which is operated by 45% owner Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) with the remaining 45% held by AngloGold Ashanti. Kibali said SOKIMO had withdrawn its first claim of this kind after it had been shown to be without foundation. Kibali also rejects the current proceedings on the basis that it was similarly spurious and without substance, and would seek its dismissal as it had done with the previous claim.  Kibali has operated for the past 12 years under a joint venture agreement with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.